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Introduction
Henoch-Schönlein purpura (HSp) is the most frequent
systemic vasculitis occurring in childhood with typical
skin involvement and concurrent signs involving joints,
gastrointestinal tube and kidney. HSp pathogenesis is
still undefined though a multifacet cytokine web is
believed to contribute in its biologic process.
Aim
To establish the relationship between serum levels of
interleukin (IL)-18 and disease outcome and assess its
feasibility to provide a marker of disease activity in the
clinical practice.
Patients/methods
We evaluated clinical/laboratory variables and serum IL-
18 in 17 unselected children (13 males, 4 females; mean
age at the onset: 7.5±3.4 years; age range: 3-16 years)
hospitalized during the last year for HSp, diagnosed by
EULAR/PRINTO/PRES criteria; the same patients were
re-evaluated after 6 months too. All results were com-
pared with 25 age-matched healthy controls. IL-12 and
IL-6 were also evaluated in a cohort of the same
patients and compared with controls.
Results
Groups were compared through non parametric tests:
Wilcoxon signed rank test for unpaired data or Mann-
Whitney U test for paired data. Logistic regression was
used to compare serum IL levels with general/clinical
variables (sex, edema of hands/feet, gastrointestinal or
renal complications, relapses and renal involvement at 6
months). Serum IL-18 levels showed no relationship
with general/clinical variables, but appeared significantly
higher at disease onset in comparison with healthy con-
trols and significantly reduced after 6 months: respec-
tively 579.1 ± 488.1 (range: 162.7- 2224.45) and 369.8 ±
193.8 (range: 118.15-744.9). Conversely, IL-12 levels at
onset were similar to controls, but significantly higher
after 6 months, whilst IL-6 levels were significantly
higher both at onset and after 6 months than in
controls.
Conclusions
The significant increase of serum IL-18 in the acute
phase of HSp might suggest its direct involvement in
the induction of the inflammatory process. Though pre-
liminary and expecting further confirmation on a larger
sample these data support the conclusion that serum
IL-18 levels reflect HSp activity.
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